Skip to main content
Fig. 3 | Allergy, Asthma & Clinical Immunology

Fig. 3

From: The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway

Fig. 3

Measurement of airway hyperresponsiveness in acetylcholine (ACH)-challenged mice. The Penh values of the four groups were measured. The results are expressed as the mean ± SD. Vehicle control (VC), atopic dermatitis (AD), corn oil treatment (COTR), and AS1517499 treatment (AS) groups (n = 10 per group). *P < 0.05

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us